Matthew W. Davis

Insider Reports History

Location
Warren, NJ
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew W. Davis:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. Chief Development Officer Common Stock 100,000 $382,000 $3.82 09 Mar 2026 Direct
Aquestive Therapeutics, Inc. Chief Development Officer Non-Qualified Stock Option (right to buy) 50,000 09 Mar 2026 Direct

Insider Reports Filed by Matthew W. Davis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AQST Aquestive Therapeutics, Inc. 09 Mar 2026 2 $0 4 Chief Development Officer 11 Mar 2026, 12:49
AQST Aquestive Therapeutics, Inc. 10 Nov 2025 2 $0 4 Chief Development Officer 12 Nov 2025, 09:35
AQST Aquestive Therapeutics, Inc. 03 Nov 2025 0 $0 3 Chief Development Officer 12 Nov 2025, 09:34